Excipient Qualification Subcommittee to Cooperate with FDA’s Effort to Develop Comprehensive Screening Library of Pharmaceutical Excipients

IPEC’s Excipient Qualification Committee members agreed to assist the Division of Pharmaceutical Analysis (DPA) within CDER to develop a comprehensive library of pharmaceutical excipient samples to help FDA develop its rapid screening capability. It’s purpose will be to assist FDA in surveillance of raw materials and finished products through rapid screening techniques to better identify materials in need of more in depth analysis - in order to prevent counterfeit, contaminated and mislabeled substances from entering the market and causing harm.

The subcommittee will be headed by Dr. Philip Merrell, Technical Marketing Manager of Jost Chemical Company, and Dr. Buhse, Director of DPA.

To learn more about the project - access Dr. Buhse’s slides by clicking here. 
 

A Food Industry Update on Economically Motivated Adulteration - And how to test for it.

Slides presented at IFPAC (January 2011) by Joseph Scimeca, Ph.D., Director, Global Regulatory Affairs, Corporate Food Safety and Regulatory Affairs, Cargill.

Click to access.